中医药现代化是实现健康中国战略的重要支撑，突破中医药系统性、复杂性等关键问题，构建符合中医药特点的中药质量评价体系是迈向中药现代化的重要基础，特别是中药复方制剂质量评价成为中药质量评价的主要挑战。通过对近年来中药复方制剂质量评价的主要研究方法，特别是对整合质量评价的研究进展进行系统梳理，并就未来中药复方制剂质量评价体系关键要素和特征进行了展望，旨在更好地推动中药复方制剂的整合质量评价向科学化、多元化、可控化方向发展，服务中药产业高质量发展和新质生产力形成。

The modernization of traditional Chinese medicine (TCM) serves as a crucial pillar in advancing Healthy China Strategy. Addressing key issues of systematicity and complexity in TCM and establishing a quality evaluation system with its unique characteristics are foundational to its modernization. Notably, the quality assessment of TCM compound preparations poses a significant challenge in this field. This article reviews the main research methods in the quality evaluation of TCM compound preparations, with a particular focus on the progress in integrated quality assessment. It also looks into future trends in modern quality evaluations specific to TCM compound preparations, conducing to promotion of the integrated quality evaluation towards a scientific, diversified, and controllable level. It will facilitate the high-quality development of TCM industry and the formation of new productive forces.

R283

国家自然科学基金资助项目（82204769）;现代中医药海河实验室科技项目（22HHZYSS00007）